These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 28592533)

  • 1. MicroRNAs of Epstein-Barr Virus Control Innate and Adaptive Antiviral Immunity.
    Albanese M; Tagawa T; Buschle A; Hammerschmidt W
    J Virol; 2017 Aug; 91(16):. PubMed ID: 28592533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNAs of Epstein-Barr Virus Attenuate T-Cell-Mediated Immune Control
    Murer A; Rühl J; Zbinden A; Capaul R; Hammerschmidt W; Chijioke O; Münz C
    mBio; 2019 Jan; 10(1):. PubMed ID: 30647153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of Viral and Host microRNAs in Immune Regulation of Epstein-Barr Virus-Associated Diseases.
    Iizasa H; Kim H; Kartika AV; Kanehiro Y; Yoshiyama H
    Front Immunol; 2020; 11():367. PubMed ID: 32194570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An update: Epstein-Barr virus and immune evasion via microRNA regulation.
    Zuo L; Yue W; Du S; Xin S; Zhang J; Liu L; Li G; Lu J
    Virol Sin; 2017 Jun; 32(3):175-187. PubMed ID: 28669004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diverse herpesvirus microRNAs target the stress-induced immune ligand MICB to escape recognition by natural killer cells.
    Nachmani D; Stern-Ginossar N; Sarid R; Mandelboim O
    Cell Host Microbe; 2009 Apr; 5(4):376-85. PubMed ID: 19380116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr virus microRNAs reduce immune surveillance by virus-specific CD8+ T cells.
    Albanese M; Tagawa T; Bouvet M; Maliqi L; Lutter D; Hoser J; Hastreiter M; Hayes M; Sugden B; Martin L; Moosmann A; Hammerschmidt W
    Proc Natl Acad Sci U S A; 2016 Oct; 113(42):E6467-E6475. PubMed ID: 27698133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epstein-Barr Virus miR-BART6-3p Inhibits the RIG-I Pathway.
    Lu Y; Qin Z; Wang J; Zheng X; Lu J; Zhang X; Wei L; Peng Q; Zheng Y; Ou C; Ye Q; Xiong W; Li G; Fu Y; Yan Q; Ma J
    J Innate Immun; 2017; 9(6):574-586. PubMed ID: 28877527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune Evasion by Epstein-Barr Virus.
    Ressing ME; van Gent M; Gram AM; Hooykaas MJ; Piersma SJ; Wiertz EJ
    Curr Top Microbiol Immunol; 2015; 391():355-81. PubMed ID: 26428381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. All for one and one for all: herpesviral microRNAs close in on their prey.
    Dölken L; Jonjic S
    Cell Host Microbe; 2009 Apr; 5(4):315-7. PubMed ID: 19380110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EBV MicroRNA BART16 Suppresses Type I IFN Signaling.
    Hooykaas MJG; van Gent M; Soppe JA; Kruse E; Boer IGJ; van Leenen D; Groot Koerkamp MJA; Holstege FCP; Ressing ME; Wiertz EJHJ; Lebbink RJ
    J Immunol; 2017 May; 198(10):4062-4073. PubMed ID: 28416598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [History of resaerch on Epstein-Barr virus--target cells of infection, and disease].
    Ohga S
    Uirusu; 2014; 64(1):67-74. PubMed ID: 25765982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Epstein-Barr Virus Immunoevasins BCRF1 and BPLF1 Are Expressed by a Mechanism Independent of the Canonical Late Pre-initiation Complex.
    McKenzie J; Lopez-Giraldez F; Delecluse HJ; Walsh A; El-Guindy A
    PLoS Pathog; 2016 Nov; 12(11):e1006008. PubMed ID: 27855219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human B cells on their route to latent infection--early but transient expression of lytic genes of Epstein-Barr virus.
    Kalla M; Hammerschmidt W
    Eur J Cell Biol; 2012 Jan; 91(1):65-9. PubMed ID: 21450364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Regulation and evasion of host immune responses by Epstein-Barr virus].
    Xiao N; Chen Q; Cai S
    Wei Sheng Wu Xue Bao; 2016 Jan; 56(1):19-25. PubMed ID: 27305776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Viral miRNAs exploiting the endosomal-exosomal pathway for intercellular cross-talk and immune evasion.
    Pegtel DM; van de Garde MD; Middeldorp JM
    Biochim Biophys Acta; 2011; 1809(11-12):715-21. PubMed ID: 21855666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clustered microRNAs of the Epstein-Barr virus cooperatively downregulate an epithelial cell-specific metastasis suppressor.
    Kanda T; Miyata M; Kano M; Kondo S; Yoshizaki T; Iizasa H
    J Virol; 2015 Mar; 89(5):2684-97. PubMed ID: 25520514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EBV lytic-phase protein BGLF5 contributes to TLR9 downregulation during productive infection.
    van Gent M; Griffin BD; Berkhoff EG; van Leeuwen D; Boer IG; Buisson M; Hartgers FC; Burmeister WP; Wiertz EJ; Ressing ME
    J Immunol; 2011 Feb; 186(3):1694-702. PubMed ID: 21191071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr Virus MicroRNA miR-BART20-5p Suppresses Lytic Induction by Inhibiting BAD-Mediated caspase-3-Dependent Apoptosis.
    Kim H; Choi H; Lee SK
    J Virol; 2016 Feb; 90(3):1359-68. PubMed ID: 26581978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multifunctional non-coding Epstein-Barr virus encoded RNAs (EBERs) contribute to viral pathogenesis.
    Iwakiri D
    Virus Res; 2016 Jan; 212():30-8. PubMed ID: 26292159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The biological properties of different Epstein-Barr virus strains explain their association with various types of cancers.
    Tsai MH; Lin X; Shumilov A; Bernhardt K; Feederle R; Poirey R; Kopp-Schneider A; Pereira B; Almeida R; Delecluse HJ
    Oncotarget; 2017 Feb; 8(6):10238-10254. PubMed ID: 28052012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.